BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 31273201)

  • 1. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
    Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D
    Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
    Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X
    Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
    Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFITM3/STAT3 axis promotes glioma cells invasion and is modulated by TGF-β.
    Wang H; Tang F; Bian E; Zhang Y; Ji X; Yang Z; Zhao B
    Mol Biol Rep; 2020 Jan; 47(1):433-441. PubMed ID: 31637620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
    Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
    Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
    Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
    Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
    Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
    Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway.
    Li Q; Liu X; Zhao C
    J Cell Biochem; 2019 Sep; 120(9):15098-15105. PubMed ID: 31131472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
    Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
    Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-β/SMAD signaling to suppress cell migration and invasion.
    Cheng HP; Huang CJ; Tsai ML; Ong HT; Cheong SK; Choo KB; Chiou SH
    Int J Med Sci; 2021; 18(8):1798-1809. PubMed ID: 33746597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation and biological function of transmembrane protein 119 in osteosarcoma.
    Jiang ZH; Peng J; Yang HL; Fu XL; Wang JZ; Liu L; Jiang JN; Tan YF; Ge ZJ
    Exp Mol Med; 2017 May; 49(5):e329. PubMed ID: 28496199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
    Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FMNL1 down-regulation suppresses bone metastasis through reducing TGF-β1 expression in non-small cell lung cancer (NSCLC).
    Yang XY; Liao JJ; Xue WR
    Biomed Pharmacother; 2019 Sep; 117():109126. PubMed ID: 31387165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
    Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
    Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
    Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
    Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
    Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.